Polyphenols
(PFs)
are
compounds
found
in
fruits
and
vegetables,
known
for
their
health-related
benefits,
mainly
including
antioxidant,
antiinflammatory,
anticancer
properties.
However,
efficacy
is
limited
by
poor
bioavailability
due
to
issues
like
low
solubility,
rapid
metabolism,
extensive
excretion.
Thus,
research
has
focused
on
improving
delivery
systems,
such
as,
example,
nanoparticles,
hydrogels,
cocrystals,
or
conjugation
with
carrier
molecules,
which
may
protect
PFs
from
degradation,
improve
and/or
facilitate
targeted
cancer
cells.
promising
modulating
cancer-related
pathways
cell
proliferation
death,
metastatic
invasion,
though
translation
patients
hindered
complex
mechanisms.
This
review
analyzes
factors
that
affect
PF
bioavailability,
evidences
of
vivo
effects
animal
models
mechanisms,
results
clinical
trials,
strategies
enhance
bioavailability.
The
idea
need
directly
interact
the
challenged.
Future
aims
optimize
combine
standard
treatments,
explore
epigenetic
effects,
modulation
tumor
microenvironment,
interactions
gut
microbiota.
Advances
personalized
medicine
structural
modifications
stability
absorption
could
further
potential.
Despite
challenges,
remain
a
avenue
complementary
oncotherapy
solutions.
Reviews in Cardiovascular Medicine,
Journal Year:
2024,
Volume and Issue:
25(7)
Published: July 2, 2024
Heart
failure
(HF)
is
a
clinical
syndrome
characterizing
by
typical
physical
signs
and
symptomatology
resulting
from
reduced
cardiac
output
and/or
intracardiac
pressure
at
rest
or
under
stress
due
to
structural
functional
abnormalities
of
the
heart.
HF
often
final
stage
all
cardiovascular
diseases
significant
risk
factor
for
sudden
arrest,
death,
liver
kidney
failure.
Current
pharmacological
treatments
can
only
slow
progression
recurrence
HF.
With
advancing
research
into
gut
microbiome
its
metabolites,
one
such
trimethylamine
N-oxide
(TMAO)—has
been
implicated
in
advancement
correlated
with
poor
prognosis
patients
However,
precise
role
TMAO
has
not
yet
clarified.
This
review
highlights
concludes
available
evidence
potential
mechanisms
associated
HF,
hope
contributing
new
insights
diagnosis
prevention
International Journal of Oncology,
Journal Year:
2024,
Volume and Issue:
65(1)
Published: June 6, 2024
Several
studies
have
indicated
that
the
gut
microbiome
and
tumor
microbiota
may
affect
tumors.
Emerging
metabolomics
research
illustrates
need
to
examine
variations
in
microbial
metabolite
composition
between
patients
with
cancer
healthy
individuals.
Microbial
metabolites
can
impact
progression
of
tumors
immune
response
by
influencing
a
number
mechanisms,
including
modulation
system,
or
immune‑related
signaling
pathways,
epigenetic
modification
proteins
DNA
damage.
also
alleviate
side
effects
drug
resistance
during
chemotherapy
immunotherapy,
while
effectively
activating
system
exert
immunotherapy.
Nevertheless,
on
immunity
be
both
beneficial
harmful,
potentially
influenced
concentration
specific
type.
The
present
review
summarizes
roles
various
different
solid
tumors,
alongside
their
influence
treatment.
Additionally,
clinical
trials
evaluating
therapeutic
related
microbes
been
listed.
In
summary,
studying
metabolites,
which
play
crucial
role
interaction
could
lead
identification
new
supplementary
treatments
for
cancer.
This
has
potential
improve
effectiveness
treatment
enhance
patient
prognosis.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: June 4, 2024
Abstract
Gut
microbiota
plays
a
crucial
role
in
gastrointestinal
tumors.
Additionally,
gut
microbes
influence
the
progression
of
esophageal
cancer.
However,
major
bacterial
genera
that
affect
invasion
and
metastasis
cancer
remain
unknown,
underlying
mechanisms
unclear.
Here,
we
investigated
flora
metabolites
patients
with
squamous
cell
carcinoma
found
abundant
Bacteroides
increased
secretion
entry
surface
antigen
lipopolysaccharide
(LPS)
into
blood,
causing
inflammatory
changes
body.
We
confirmed
these
results
mouse
model
4NQO-induced
situ
further
identified
epithelial–mesenchymal
transition
(EMT)
occurrence
TLR4/Myd88/NF-κB
pathway
activation
vitro
experiments
revealed
LPS
from
fragile
promoted
proliferation,
migration,
invasion,
induced
EMT
by
activating
pathway.
These
reveal
are
closely
associated
through
higher
response
level
signaling
both
common
to
inflammation
tumors
LPS,
providing
new
biological
target
for
prevention
or
treatment.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(6), P. 1235 - 1235
Published: June 19, 2024
The
discovery
of
immune
checkpoints
(CTLA-4,
PD-1,
and
PD-L1)
their
impact
on
the
prognosis
oncological
diseases
have
paved
way
for
development
revolutionary
treatments.
These
treatments
do
not
combat
tumors
with
drugs
“against”
cancer
cells
but
rather
support
enhance
ability
system
to
respond
directly
tumor
growth
by
attacking
lymphocytes.
It
has
now
been
widely
demonstrated
that
presence
an
adequate
response,
essentially
represented
number
TILs
(tumor-infiltrating
lymphocytes)
present
in
mass
decisively
influences
response
disease.
Therefore,
immunotherapy
is
based
cannot
be
carried
out
without
increase
lymphocytic
at
site,
thereby
limiting
nullifying
certain
evasion
mechanisms,
particularly
those
expressed
activity
(under
positive
physiological
conditions)
restrain
against
transformed
cells.
Immunotherapy
experimental
phase
decades,
its
excellent
results
made
it
a
cornerstone
many
pathologies,
especially
when
combined
chemotherapy
radiotherapy.
Despite
these
successes,
significant
patients
(approximately
50%)
treatment
or
develop
resistance
early
on.
microbiota,
composition,
our
modulate
can
treatments,
reducing
side
effects
increasing
sensitivity
effectiveness.
Numerous
studies
published
high-ranking
journals
confirm
microbial
balance,
bacteria
capable
producing
short-chain
fatty
acids
(SCFAs),
butyrate,
essential
only
chemoradiotherapy
also
better
and,
therefore,
prognosis.
This
opens
up
possibility
favorable
modulation
microbiota
could
become
complementary
standard
therapies.
brief
review
aims
highlight
key
aspects
using
precision
probiotics,
such
as
Clostridium
butyricum,
produce
butyrate
improve
checkpoint
thus,
diseases.
Academia molecular biology and genomics.,
Journal Year:
2025,
Volume and Issue:
2(2)
Published: April 1, 2025
This
review
examines
the
role
of
gut
microbiota
in
activation
Wnt/β-catenin
signaling
pathway
and
its
impact
on
cancer
progression
via
YAP/TAZ
activation.
Yes-associated
protein,
YAP,
is
a
transcriptional
coactivator
involved
regulating
gene
expression
cell
proliferation
by
interacting
with
TEA
domain
(TEAD)
transcription
factor
Hippo
pathway.
The
an
evolutionarily
conserved
that
important
for
development
tissue
homeostasis
but
was
described
as
driving
oncogenic
processes
through
activity.
In
this
regard,
metabolites
drove
tumor
activating
onto
increased
evidence.
discusses
recent
studies
modulation
effect
further
pursues
effects
treatment
prevention.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 631 - 631
Published: Jan. 13, 2025
Cancer
stem
cells
(CSC)
are
known
to
be
the
main
source
of
tumor
relapse,
metastasis,
or
multidrug
resistance
and
mechanisms
counteract
eradicate
them
their
activity
remain
elusive.
There
different
hypotheses
that
claim
origin
CSC
might
in
regular
(SC)
and,
due
accumulation
mutations,
these
normal
become
malignant,
any
malignant
cell
that,
under
certain
environmental
circumstances,
acquires
all
qualities
CSC.
Multiple
studies
indicate
lifestyle
diet
represent
a
wellbeing
can
prevent
ameliorate
phenotype
In
this
review,
after
brief
introduction
SC
CSC,
we
analyze
effects
phenolic
non-phenolic
dietary
compounds
highlight
molecular
shown
link
diets
activation
colon,
breast,
prostate
cancer.
We
focus
analysis
on
specific
markers
such
as
sphere
formation,
CD
surface
markers,
epithelial–mesenchymal
transition
(EMT),
Oct4,
Nanog,
Sox2,
aldehyde
dehydrogenase
1
(ALDH1)
major
signaling
pathways
PI3K/Akt/mTOR,
NF-κB,
Notch,
Hedgehog,
Wnt/β-catenin
conclusion,
better
understanding
how
bioactive
our
influence
dynamics
raise
valuable
awareness
towards
reducing
cancer
risk.
BMC Cancer,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 4, 2025
There
have
been
previously
reported
associations
between
the
gut
microbiota,
immune
cells,
and
colorectal
cancer;
however,
specific
mechanisms
underlying
these
relationships
remain
largely
unexplored
require
further
research.
Therefore,
in
this
study,
we
aimed
to
unravel
interactions
cancer.
The
analysis
used
genome-wide
association
study
(GWAS)
data
encompassing
207
microbial
taxa
205
functional
pathways
on
731
cell
phenotypes.
Colorectal
cancer
6
581
cases
463
421
controls
were
sourced
from
Integrative
Epidemiology
Unit
Open
GWAS
Project.
Univariate
inverse-variance
weighted
Mendelian
randomization
was
identify
associated
with
Mediation
mediating
role
of
cells
link
bacteria
revealed
that
several
Actinobacteria
Firmicutes
phyla
significantly
Coriobacteriaceae
(odds
ratio
[OR]:
0.84,
95%
confidence
interval
[CI]:
0.72-0.97),
Sutterellaceae
(OR:
0.88,
CI:
0.78-0.99),
Eggerthella
0.91,
0.84-0.99),
Coriobacteriales
Collinsella
aerofaciens
0.85,
0.74-0.99),
Ruminococcus
bromii
0.83-0.99)
negatively
cancer,
whereas
Lactobacillales
1.11,
1.03-1.20),
Veillonella
1.08,
1.01-1.15),
Bifidobacterium
bifidum
1.05,
1.00-1.09)
positively
causal
pathway
CD127
CD28+
CD45RA-
CD8br
human
leukocyte
antigen
(HLA)
DR
CD33-
HLA
DR+,
mediated
11.30%
-
6.52%
effect,
respectively,
IgD-
CD38dim
%lymphocyte
14.80%
effect.
These
results
highlight
potential
microbiota
phenotypes
as
novel
treatment
strategies
for